A number of these tracers have been used for imaging ADRD, with demonstrated specificity for MAO-B over MAO-A, and discerning differences in healthy control subjects, subjects with mild cognitive impairment (MCI), and later staged AD subjects [30, 35, 40]. This evidence concerns the gene MAOB and Alzheimer disease.